InsidersTradesSigma
Browse the full record of transactions filed by Hoang Peter L., Chief Executive Officer. Director active across 1 companies, notably Marker Therapeutics, Inc.. Cumulatively, 1 filings have been recorded. The latest transaction was filed on 24 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Peter L. Hoang is President and CEO of Marker Therapeutics, Inc. He leads the company and is responsible for its strategy and operations. His leadership is crucial for the company's development and innovation.